Institution Name: Degree: Completion Date: Field of Study: University of Groningen, The Netherlands PhD 12/2006 Pharmacology
|
|
- Lucy Barber
- 5 years ago
- Views:
Transcription
1 Harm Maarsingh, PhD Associate Professor of Pharmaceutical Sciences Lloyd L. Gregory School of Pharmacy Palm Beach Atlantic University 901 S Flagler Drive West Palm Beach, FL (phone) (fax) harm_maarsingh@pba.edu EDUCATION/TRAINING Institution Name: Degree: Completion Date: Field of Study: University of Groningen, The Netherlands PhD 12/2006 Pharmacology University of Groningen, The Netherlands MSc 08/2001 Pharmacy Certifications: 2016 Good Clinical Practice (awarded by Dr. Gizurarson, University of Iceland) Certified Pharmacologist (awarded by Dutch Pharmacological Society) Legal status (art. 9) to ethically conduct animal experiments and to apply for research projects grants involving animal experimentation (The Netherlands) Legal status to conduct experiments involving radioactivity at the 5B level (The Netherlands) Safe microbiological experimentation, providing legal status for experimentation at the ML-1 and ML-2 level (The Netherlands).
2 POSITIONS AND HONORS Positions and Employment: 2013 present: Associate Professor of Pharmaceutical Sciences, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL : Lecturer, Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands (0.5 fte) : Post-doctoral fellow at the department of Molecular Pharmacology, University of Groningen on a research grant funded by the Schering-Plough Research Institute (later MSD). Part of this research was performed at the department of Physiology, University of Massachusetts Medical School, Worcester, MA. (0.5 fte from September 2009) : Post-doctoral fellow at the department of Molecular Pharmacology, University of Groningen on a research grant funded by NV Organon, Oss (later Schering- Plough). Part of this research was performed at the department of Asthma, Allergy and Lung Biology, King s College London (UK). Awards: 2010 International Trainee Travel Award - granted by the American Thoracic Society 2007 Thesis Award - granted by the Netherlands Society for Pharmaceutical Sciences for the best thesis in the field of Pharmaceutical Sciences defended in International Trainee Travel Award - granted by the American Thoracic Society RESEARCH STATEMENT Main expertise is in airway pharmacology, specifically in relation to preclinical in vivo, ex vivo and in vitro models of asthma and COPD. Within this context, the role of the L-arginine metabolome (arginase, nitric oxide synthase), the camp signaling pathway (β-agonists, camp effectors and A- kinase anchoring proteins) and the Fstl1/BMP4 pathway in airway inflammation, hyperresponsiveness and remodeling is studied. An important strength is the integration of mechanistic in vitro and ex vivo studies with proof of concept in vivo studies, which enables not only the identification of new drug targets but also the mechanisms of action. Research collaborations exist with Drs Nornoo, Santini and Mitroka (Palm Beach Atlantic University), Drs Schmidt, Meurs, Gosens, Hirsch and Dekker (University of Groningen, The Netherlands), Dr Halayko (University of Manitoba, Canada) and Dr. Van den Hoff (Amsterdam Medical Center, The Netherlands). For a complete list of publications follow this link: Publication List Harm Maarsingh
3 CONTRIBUTION TO SCIENCE Using guinea pig models of acute and chronic allergic asthma, I studied the role of the L-arginine metabolome, specifically the interactive role of arginase and nitric oxide synthase (NOS), in the development of airway hyperresponsiveness (AHR), airway inflammation and airway remodeling. We were the first to demonstrate that the activity of arginase is increased after the early and late asthmatic reaction in models of acute and chronic asthma, which limits the bioavailability of L- arginine to NOS leading to a deficiency of bronchodilating NO. Targeting this increased arginase activity ex vivo using the specific arginase inhibitor nor-noha prevents allergen-induced AHR by restoring normal levels of bronchodilating nitric oxide and preventing the formation of pro-contractile peroxynitrite. Increased arginase also contributes to the deficiency of neuronal NOS-derived NO in allergic asthma by limiting the bioavailability of L-arginine to neuronal NOS. Treatment with the inhaled arginase inhibitor in vivo greatly reduced the sensitivity to inhaled allergens in vivo and reduced AHR and inflammation in a guinea pig model of acute asthma. ABH also prevented allergen-induced airway remodeling, inflammation and AHR in a guinea pig model of chronic asthma. We also demonstrated that arginase activity is increased in an LPS-induced guinea pig model of COPD and that treatment with inhaled ABH in vivo prevents LPS-induced inflammatory processes and fibrosis. ABH also prevented the development of right ventricular hypertrophy a marker for pulmonary hypertension. Taken together, increased arginase represents a novel therapeutic target for the treatment of asthma and COPD. Key publications L-arginine metabolome studies: a. Meurs H, McKay S, Maarsingh H, Hamer MAM, Macic L, Molendijk N, Zaagsma J. 2002; Increased arginase activity underlies allergen-induced deficiency of cnos-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 136(3): b. Maarsingh H, Leusink J, Bos IST, Zaagsma J, Meurs H. 2006; Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res 7:1. c. Maarsingh H, Zuidhof AB, Bos IS, van Duin M, Boucher JL, Zaagsma J, Meurs H. 2008; Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am J Respir Crit Care Med 178(6): d. Maarsingh H, Bossenga BE, Bos IST, Volders HH, Zaagsma J, Meurs H. 2009, L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur Respir J 34: e. Maarsingh H, Dekkers BG, Zuidhof AB, Bos IS, Menzen MH, Klein T, Flik G, Zaagsma J, Meurs H. 2011; Increased arginase activity contributes to airway remodelling in chronic allergic asthma. Eur Respir J. 38: f. Pera T, Zuidhof AB, Smit M, Menzen MH, Klein T, Flik G, Zaagsma J, Meurs H, Maarsingh H. 2014; Arginase inhibition prevents inflammation and remodeling in a guinea pig model of COPD. J Pharmacol Exp Ther. 349(2):
4 Another ongoing research line is focused on the role of the camp signaling pathway in health and disease. The camp pathway is an important second messenger pathway and plays a crucial role in the efficacy of β-agonist, a mainstay bronchodilator. We have established the functional role of the camp effector Epac (Epac1 and Epac2) in the airways and demonstrated that activation of Epac induces airway relaxation, prevents mitogen-induced phenotypic modulation of airway smooth muscle and inhibits cigarettes smoke-induced airway inflammation. Importantly, the expression of Epac1 is reduced in lung tissue of COPD patients. Using knockout mice, we demonstrated that Epac1 and Epac2 are differentially involved in regulating inflammatory and remodeling processes in the lungs that are induced by cigarette smoke. A-kinase anchoring proteins (AKAPs) play an important role in compartmentalizing camp signaling by forming a scaffold for various proteins involved in camp signaling, such as receptors and effector proteins. Our studies revealed that AKAP-PKA interactions play an important role in regulating (patho)physiological processes in the lungs. AKAPs contribute to loss of E-cadherin expression and subsequent reduction in epithelial barrier function induced by cigarette smoke extract (CSE). AKAPs also coordinate CSE-induced inflammatory cytokine release from airway smooth muscle cells as well as the responsiveness towards β-agonists. I have also studied the effect of (a combination of) a long-acting anti-cholinergic (tiotropium), an ultra-long acting β-agonist (olodaterol) or a glucocorticosteroid (ciclesonide) on airway hyperresponsiveness, airway inflammation and airway remodeling in guinea pig models of asthma. These studies demonstrated that olodaterol synergistically enhanced the bronchoprotective effect of tiotropium in allergen-induced asthma. Key publications camp studies: a. Roscioni SS, Maarsingh H, Elzinga CRS, Schuur LJ, Menzen MH, Halayko AJ, Meurs H, Schmidt M. 2011; Epac as a novel effector in airway smooth muscle relaxation. J Cell Mol Med 15: b. Roscioni SS, Prins AG, Elzinga CR, Menzen MH, Dekkers BG, Halayko AJ, Meurs H, Maarsingh H, Schmidt M. 2011; Protein kinase A and the exchange protein directly activated by camp (Epac) modulate phenotype plasticity in human airway smooth muscle. Br J Pharmacol. 164: c. Oldenburger A, Roscioni SS, Jansen E, Menzen MH, Halayko AJ, Timens W, Meurs H, Schmidt M, Maarsingh H. 2012; Anti-inflammatory role of the camp effectors Epac and PKA: implications in chronic obstructive pulmonary disease. PLoS ONE. 7(2):e d. Schmidt M, Dekker FJ, Maarsingh H. 2012; Exchange protein directly activated by camp (epac): a multidomain camp mediator in the regulation of diverse biological functions. Pharmacol Rev. 65(2): e. Smit M, Zuidhof AB, Bos SI, Maarsingh H, Gosens R, Zaagsma J, Meurs H. 2014; Bronchoprotection by olodaterol is synergistically enhanced by tiotropium in a guinea pig model of allergic asthma. J Pharmacol Exp Ther. 348(2): f. Oldenburger A, Poppinga WJ, Kos F, de Bruin HG, Rijks W, Heijink I, Timens W, Meurs H, Maarsingh H, Schmidt M. 2014; A-kinase anchoring proteins contribute to loss of E-cadherin and bronchial epithelial barrier by cigarette smoke. Am J Physiol Cell Physiol. 306(6):C585-C597. g. Poppinga WJ, Heijink IH, Holtzer LJ, Skroblin P, Klussmann E, Halayko AJ, Timens W, Maarsingh H, Schmidt M. 2015; A-kinase-anchoring proteins coordinate inflammatory responses to cigarette smoke in airway smooth muscle. m J Physiol Lung Cell Mol Physiol. 308(8):L766- L775.
5 RESEARCH SUPPORT As main applicant $275,000 Netherlands Asthma Foundation (NAF grant ) - granted in 2012 study the role of the bone morphogenic protein (BMP) antagonist Follistatin-like 1 (Fstl1) in the pathophysiology of COPD. $275,000 Netherlands Asthma Foundation (NAF grant ) - granted in 2011 study the role of A-kinase anchoring proteins in the pathophysiology and pharmacological treatment of COPD. $22,000 Stichting Astmabestrijding - granted in 2010 study the relation between airway responsiveness and airway remodeling in COPD $2,000 Palm Beach Atlantic University Quality Initiative - granted in 2015 study the relation between allergen-induced airway constriction and histamine release in asthma $525,000 Novartis (2 grants) - granted in 2013, 2015 study the effectiveness of drugs in preventing airway constriction. As co-applicant $270,000 Netherlands Asthma Foundation (NAF grant ) - granted in 2009 study the role of the camp effector Epac (exchange protein directly activated by camp) in the pathophysiology and pharmacological treatment of COPD. $935,000 Technology Foundation STW, The Netherlands granted in 2015 developing and testing of novel arginase inhibitors for the treatment of allergic asthma. $550,000 Organon Oss (Netherlands) & Schering-Plough, Kenilworth, NJ (2 grants) - granted in 2006, 2008 study arginase as a drug target for airway hyperresponsiveness, airway inflammation and airway remodeling in in vivo guinea pig models of acute and chronic asthma and COPD. $685,000 Boehringer-Ingelheim, Ingelheim, Germany (3 grants) - granted 2009, 2010, 2011 study the (interaction) of therapeutic drugs in relation to airway hyperresponsiveness, airway inflammation and airway remodeling and in in vivo guinea pig models of acute and chronic asthma.
6 TEACHING My teaching responsibilities within the PharmD program focus mainly on pharmacology and pathophysiology of diseases in pharmaceutical sciences courses and pharmacotherapy series in the P1, P2 and P3 year. In addition, I precept APPE rotation students in various research projects in the P4 year. List of current courses: PRX 1103 PRX 1203 PRX 2145 PRX 2213 PRX 2253 PRX 2264 PHR 3152 PHR 3263 PHR 4512 PHR 4524 PHR 4534 Principles of Drug Action I Principles of Drug Action II Cardiovascular Pharmacotherapy Immunology, Biotechnology & Pharmacogenomics Gastrointestinal, Hepatic, and Renal Pharmacotherapy Endocrine and Musculoskeletal Pharmacotherapy Special Topics in Pharmacotherapy Hematologic, Oncologic, and Immunologic Pharmacotherapy Pharmacy Missions Advanced Biomedical and Pharmaceutical Research - Advanced Pharmacy Practice Experience I Advanced Biomedical and Pharmaceutical Research - Advanced Pharmacy Practice Experience II SERVICE Lloyd L. Gregory School of Pharmacy present Research & Resource Committee present Evaluation & Assessment Committee present Pharmacy Faculty Search Taskforce present Spiritual Advisory Council Curriculum & Academic Policy Committee 2014 Faculty promotion committee Strategic Plan Advisory Council Curricular Taskforce 2015 OSCE Taskforce 2016 Faculty Workload Taskforce Palm Beach Atlantic University present Faculty Promotion and Evaluation Committee Faculty Research Committee Joint Committee for Sabbatical Leaves and Course Load Reductions
7 Scientific Community present Reviewer for various International Scientific Journals & Grant Organizations 2013 Co-organizer of the 8th International Young Investigators Meeting on airway smooth muscle and fibroblasts, Groningen, The Netherlands Chairman of the Program Committee of the Dutch Pharmacological Society Member of the Scientific Committee of the FIGON Dutch Medicine Days Session Chair at the FIGON Dutch Medicine Days Judge for Best Poster Presenter Award FIGON Dutch Medicine Days Member of the Core Group and Management Committee of the European Union COST Action Epigenetics: bench to bedside (TD0905) Chairman of the COST working group Functional consequences of epigenetics (until May 2012)
University of Groningen. Compartmentalized signaling in the lung Poppinga, Wilfred Jelco
University of Groningen Compartmentalized signaling in the lung Poppinga, Wilfred Jelco IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
More informationMajor role of the extracellular matrix in airway smooth muscle phenotype plasticity Dekkers, Bart
University of Groningen Major role of the extracellular matrix in airway smooth muscle phenotype plasticity Dekkers, Bart IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationArginase in Asthma Recent Developments in Animal and Human Studies
20 The Open Nitric Oxide Journal, 2010, 2, 20-36 Open Access Arginase in Asthma Recent Developments in Animal and Human Studies Michelle L. North 1, Herman Meurs 2, Johan Zaagsma 2, Jeremy A. Scott 1,3,
More informationAirway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Eur Respir J 2008; 32: 487 502 DOI: 10.1183/09031936.00023608 CopyrightßERS Journals Ltd 2008 SERIES CELL AND ANIMAL STUDIES IN RESPIRATORY MEDICINE Edited by R. Farré and A.T. Dinh-Xuan Number 3 in this
More informationLearning Outcomes. Systems Pharmacology PHAR3320. Nerves of the Respiratory Tract. Dr Fernandes
Systems Pharmacology PHAR3320 Nerves of the Respiratory Tract Dr Fernandes Learning Outcomes By the end of this lecture, students should be able to describe nerve pathways that innervate the airways discuss
More informationTreatment of asthmatic bronchoconstriction by percutaneous low voltage vagal nerve stimulation: case report.
ISPUB.COM The Internet Journal of Asthma, Allergy and Immunology Volume 7 Number 2 Treatment of asthmatic bronchoconstriction by percutaneous low voltage vagal nerve stimulation: case P Sepulveda, G Bohill,
More informationBronchial Provocation Results: What Does It Mean?
Bronchial Provocation Results: What Does It Mean? Greg King 1 Department of Respiratory Medicine, Royal North Shore Hospital, St Leonards 2065 2 Woolcock Institute of Medical Research and Sydney Medical
More informationIncreased arginase activity contributes to airway remodelling in
ERJ Express. Published on February 10, 2011 as doi: 10.1183/09031936.00057710 Maarsingh - 1 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Harm Maarsingh 1, Bart
More informationPATHOPHYSIOLOGICAL PROCESS TEMPLATE
1 PATHOPHYSIOLOGICAL PROCESS TEMPLATE DISEASE: Chronic obstructive pulmonary disease (COPD) DEFINITION: COPD can be defined as a disease in which there is a significant damage to the lungs thus reducing
More information12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More informationBETTER DEFINING AIRWAYS DISEASE WITH TECHNEGAS
cyclopharm 17 May 2018 The Manager Company Announcements Office Australian Securities Exchange Limited 20 Bridge Street Sydney NSW 2000 cyclomedica technegas ultralute Cyclopharm Ltd ABN 74 116 931 250
More informationSearching for Targets to Control Asthma
Searching for Targets to Control Asthma Timothy Craig Distinguished Educator Professor Medicine and Pediatrics Penn State University Hershey, PA, USA Inflammation and Remodeling in Asthma The most important
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationDefining Asthma: Bronchial Hyperresponsiveness. Defining Asthma: Clinical Criteria. Impaired Ventilation in Asthma. Dynamic Imaging of Asthma
Defining Asthma: Clinical Criteria Defining Asthma: Bronchial Hyperresponsiveness Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine,
More informationThe FDA Critical Path Initiative
The FDA Critical Path Initiative Clinical Considerations for Demonstration of Dose-response for Inhaled Corticosteroids - Exhaled Nitric Oxide Model Badrul A. Chowdhury, MD, PhD Director Division of Pulmonary
More informationREVIEW Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectivesbph_
British Journal of Pharmacology (2009), 158, 652 664 2009 The Authors Journal compilation 2009 The British Pharmacological Society All rights reserved 0007-1188/09 www.brjpharmacol.org REVIEW Arginase:
More informationArginase Inhibition Protects against Allergen-induced Airway Obstruction, Hyperresponsiveness, and Inflammation
Arginase Inhibition Protects against Allergen-induced Airway Obstruction, Hyperresponsiveness, and Inflammation Harm Maarsingh 1, Annet B. Zuidhof 1, I. Sophie T. Bos 1, Marcel van Duin 2, Jean-Luc Boucher
More informationThe mode of action of anticholinergics in asthma
BACK TO BASICS ASTHMA The mode of action of anticholinergics in asthma Reinoud Gosens 1 and Nicholas Gross 2 Affiliations: 1 University of Groningen, Groningen, The Netherlands. 2 University Medical Research
More informationCME/CE POSTTEST CME/CE QUESTIONS
CME/CE POSTTEST CME/CE QUESTIONS Controlling Asthma Severity: Identifying Unmet Needs and Optimizing Therapeutic Options There are no fees for participating in and receiving continuing medical education
More informationLOOK, FEEL AND LIVE BETTER. Respiratory Health
LOOK, FEEL AND LIVE BETTER Respiratory Health Respiratory health: hay fever and asthma Airway obstruction and symptoms in asthma and hay fever alike are the result of inappropriate responses of the body
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Action plans, and asthma self-management, 47 51 education on, 48 49 health literacy-based education on, 49 50 Airway hyperresponsiveness, assessment
More informationBronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness
ORIGINAL ARTICLE Bronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness Bojana B. Petanjek, MD, Sanja P. Grle, MD, Dubravka Pelicarić, MD, and
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationOutcomes Summary. February 3-6, 2016 Keystone, Colorado
Outcomes Summary February 3-6, 2016 Keystone, Colorado Executive Summary Activity Details Background: The National Jewish Health Annual The Pulmonary and Allergy Update highlights insights and recent advances
More informationSystems Pharmacology Respiratory Pharmacology. Lecture series : General outline
Systems Pharmacology 3320 2017 Respiratory Pharmacology Associate Professor Peter Henry (Rm 1.34) Peter.Henry@uwa.edu.au Division of Pharmacology, School of Biomedical Sciences Lecture series : General
More informationAsthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More informationCombination therapy of tiotropium and ciclesonide attenuates airway inflammation and remodeling in a guinea pig model of chronic asthma
Kistemaker et al. Respiratory Research (2016) 17:13 DOI 10.1186/s12931-016-0327-6 RESEARCH Open Access Combination therapy of tiotropium and ciclesonide attenuates airway inflammation and remodeling in
More informationJuxtaposition vs Synergistic Effects
Inventive step Juxtaposition vs Synergistic Effects Rosa María Domínguez Martínez Head of Department of Quality and Technical Opinions Patentability requirements The Industrial Property Law establish:
More informationRespiratory Health L O O K, F E E L A N D L I V E B E T T E R
LOOK, FEEL AND LIVE BET TER Respiratory health: hay-fever and asthma Airway obstruction and symptoms in asthma and hay-fever alike are the result of inappropriate responses of the body s immune system
More informationSystems Pharmacology Respiratory Pharmacology. Lecture series : General outline
Systems Pharmacology 3320 2017 Respiratory Pharmacology Associate Professor Peter Henry (Rm 1.34) Peter.Henry@uwa.edu.au Division of Pharmacology, School of Biomedical Sciences Lecture series : General
More informationArginase and arginine dysregulation in asthma.
Arginase and arginine dysregulation in asthma. Renee C. Benson, Bay Area Pediatric Pulmonary Medical Corporation Karen A. Hardy, Children's Hospital & Research Center Oakland Claudia R. Morris, Emory University
More information10801 Sixth St, Rancho Cucamonga, CA Tel (909) Fax (909) Visit our web site at:
for the Diagnosis and Management of Asthma and Other Pulmonary Disorders IEHP Policy: Based on a review of the currently available literature, there is insufficient evidence to support the use of FE NO
More informationCOPD and Asthma: Similarities and differences Prof. Peter Barnes
and Asthma: Similarities and Differences and Asthma: 1 Imperial College Peter Barnes FRS, FMedSci, National Heart & Lung Institute Imperial College, London, UK p.j.barnes@imperial.ac.uk Royal Brompton
More informationRole of the Brain-Lung Axis in Fatigue
Role of the Brain-Lung Axis in Fatigue Y.S. Prakash, M.D., Ph.D. Professor of Anesthesiology and Physiology Chair, Department of Physiology & BME Mayo Clinic Rochester, Minnesota, USA Fatigue in Chronic
More informationSuitable Patient Populations and Study Designs for rapid PoC
Suitable Patient Populations and Study Designs for rapid PoC Dr. med. Anton Drollmann Translational Medicine Respiratory Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, CH 22th
More informationE-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling
E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling Ruby Pawankar, MD, Ph.D. FRCP, FAAAAI Prof. Div of Allergy, Dept of Pediatrics Nippon Medical School Tokyo, Japan pawankar.ruby@gmail.com
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationCurriculum Vitae Athagran Nakham, B.S.(Pharm), Pharm.D.(Pharm Care)
Curriculum Vitae Athagran Nakham, B.S.(Pharm), Pharm.D.(Pharm Care) Office Address: Home Address: Department of Pharmacy Practice Nivej 6 building, room 711 Faculty of Pharmaceutical Sciences Naresuan
More informationImpact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma
American Association for Respiratory Care Asthma Educator Certification Prep Course Asthma Epidemiology and Pathophysiology Robert C. Cohn, MD, FAARC MetroHealth Medical Center Cleveland, OH Impact of
More informationGlucocorticosteroids and 2 -Adrenoceptor Agonists Synergize to Inhibit Airway Smooth Muscle Remodeling S
Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2012/06/08/jpet.112.195867.dc1 1521-0103/12/3423-780 787$25.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL
More informationPaediatric Asthma. Edited by Kai-Håkon Carlsen and Jorrit Gerritsen NUMBER 56 / JUNE 2012
NUMBER 56 / JUNE 2012 Paediatric Asthma Edited by Kai-Håkon Carlsen and Jorrit Gerritsen European Respiratory Monograph 56, June 2012 Paediatric Asthma Published by European Respiratory Society 2012 June
More informationPublic Dissemination
1. THE ASTHMA CONDITION 9 18 3 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationChronic respiratory disease: towards better treatments
Chronic respiratory disease: towards better treatments Alaina J. Ammit PhD Alaina.Ammit@uts.edu.au Professor of Respiratory Pharmacology, UTS Director, Woolcock Emphysema Centre, Woolcock Institute of
More informationRobert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network
Robert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network Robert.kruklitis@lvh.com Correlation of a Asthma pathophyisology with basic science Asthma (Physiology) Bronchodilators
More informationAND COPD ADVANCES IN COMBINATION THERAPY FOR ASTHMA. Jan Lotvall. Editor. Krefting Research Centre, University of Gothenburg,
ADVANCES IN COMBINATION THERAPY FOR ASTHMA AND COPD Editor Jan Lotvall Krefting Research Centre, University of Gothenburg, Sweden A Wiley Sons, Ltd., Publication Contents Contributors xi Preface 1 Similarities
More informationCME/CE QUIZ CME/CE QUESTIONS
CME/CE QUIZ CME/CE QUESTIONS Continuing Medical Education Accreditation The University of Cincinnati College of Medicine designates this educational activity for a maximum of 2 Category 1 credits toward
More informationMedicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air
Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air through the airways. As asthma, COPD ( chronic bronchitis
More informationExhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma
Exhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma Jason Debley, MD, MPH Assistant Professor, Pediatrics Division of Pulmonary Medicine University of Washington School of
More informationAsymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)
Int. J. Mol. Sci. 214, 15, 662-671; doi:1.339/ijms154662 Article OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-67 www.mdpi.com/journal/ijms Asymmetric Dimethylarginine in Chronic Obstructive
More informationAsthma Management for the Athlete
Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric
More informationInflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids Boorsma, M.
UvA-DARE (Digital Academic Repository) Inflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids Boorsma, M. Link to publication Citation for published version
More informationBIOMEDICAL SCIENCES GRADUATE PROGRAM SUMMER 2014
THE OHIO STATE UNIVERSITY BIOMEDICAL SCIENCES GRADUATE PROGRAM SUMMER 2014 Jessica Rose Napolitano PhD Candidate Examination of the role of ZIP8 and cadmium in the development of Chronic Obstructive Pulmonary
More informationBoehringer Ingelheim and investment in R&D. Volker Barkmann
Boehringer Ingelheim and investment in R&D Volker Barkmann I. Our Corporation Boehringer Ingelheim in brief Boehringer Ingelheim Center Our headquarters in Ingelheim, Germany Family-owned global corporation
More informationTHE COPD-ASTHMA OVERLAP SYNDROME
THE COPD-ASTHMA OVERLAP SYNDROME NICOLA A. HANANIA, MD, MS, FRCP(C), FCCP, FACP ASSOCIATE PROFESSOR OF MEDICINE DIRECTOR OF ASTHMA & COPD CLINICAL RESEARCH CENTER BAYLOR COLLEGE OF MEDICINE HOUSTON, TX
More informationCOPD: From Phenotypes to Endotypes. MeiLan K Han, M.D., M.S. Associate Professor of Medicine University of Michigan, Ann Arbor, MI
COPD: From Phenotypes to Endotypes MeiLan K Han, M.D., M.S. Associate Professor of Medicine University of Michigan, Ann Arbor, MI Presenter Disclosures MeiLan K. Han Consulting Research support Novartis
More informationOptimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers?
Disclosures: Optimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers? Stanley Fineman, MD Past-President, American College of Allergy, Asthma & Immunology Adjunct Associate
More informationCOPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013
COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013 None Disclosures Definitions Asthma Asthma is a chronic inflammatory
More informationChapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators Clinical Indications for Use Indication for anticholinergic bronchodilator COPD maintenance Indication for combined anticholinergic and β-agonist
More informationASTHMA TREATMENT EFFICACY ASSESSMENT BY FeNO MEASUREMENT
Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 5 (54) No. 2-2012 ASTHMA TREATMENT EFFICACY ASSESSMENT BY FeNO MEASUREMENT Dana ALEXANDRESCU 1 Abstract: The author of
More informationCURRICULUM VITAE present: Associate Professor, Pharmaceutical Sciences School of Pharmacy, Palm Beach Atlantic University
CURRICULUM VITAE EDWIN SANTINI RIOS, PH.D. Palm Beach Atlantic University Lloyd L. Gregory School of Pharmacy West Palm Beach, FL 33416 Tel: (787) 298-3116 Email: EDWIN_SANTINI@pba.edu EDUCATION AND WORK
More informationEvaluating Exam Review Book and Guide
Pharmacy Prep Evaluating Exam Review Book and Guide Misbah Biabani, Ph.D Director Toronto Institute of Pharmaceutical Sciences (TIPS) Inc. Toronto, ON M2N 6K7 Pharmacy Prep Professional Exams Preparation
More informationSpecific Basic Standards for Osteopathic Fellowship Training in Pulmonary / Critical Care Medicine
Specific Basic Standards for Osteopathic Fellowship Training in Pulmonary / Critical Care Medicine American Osteopathic Association and American College of Osteopathic Internists BOT Rev. 2/2011 These
More informationNational Asthma Educator Certification Board Detailed Content Outline
I. THE ASTHMA CONDITION 9 20 1 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationBitter Taste Receptors: Taking a Bigger Bite of Airway Smooth Muscle Pathophysiology
Page 1 of 6 Editorial Bitter Taste Receptors: Taking a Bigger Bite of Airway Smooth Muscle Pathophysiology Charles W. Emala, Sr. Department of Anesthesiology Columbia University, New York, New York Contact
More informationClass of We are pleased to provide support for the following new investigators who make up the Parker B. Francis Fellowship
The Parker B. Francis Fellowship Program provides career development support to M.D. and Ph.D. scientists embarking on careers in clinical, laboratory or translational science related to Pulmonary, Critical
More informationIoana Agache Transylvania University Brasov. Precision medicine in allergy and asthma
Ioana Agache Transylvania University Brasov Precision medicine in allergy and asthma Precision medicine and precision health Personalized care based on molecular, immunologic and functional endotyping
More informationAllergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.
Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 75: Approach to Infants and Children with Asthma
More informationCURRICULUM VITAE. Sandra Tecklenburg Lund
CURRICULUM VITAE Sandra Tecklenburg Lund EDUCATION PhD. Human Performance-Exercise Physiology Minors: Physiology and Biochemistry Indiana University 2009 Dissertation: Comparative and Synergistic Effects
More informationMajor role of the extracellular matrix in airway smooth muscle phenotype plasticity Dekkers, Bart
University of Groningen Major role of the extracellular matrix in airway smooth muscle phenotype plasticity Dekkers, Bart IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationPhenotypes of asthma; implications for treatment. Medical Grand Rounds Feb 2018 Jim Martin MD DSc
Phenotypes of asthma; implications for treatment Medical Grand Rounds Feb 2018 Jim Martin MD DSc No conflicts to declare Objectives To understand the varied clinical forms of asthma To understand the pathobiologic
More informationUNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE Plan of the course Basics of Pediatric Allergy Academic year 2015/2016 I. COURSE AIMS COURSE OUTLINE The specialty of allergy involves the management of a wide range
More informationPHARMACY PRACTICE (PHM PRAC)
Pharmacy Practice (PHM PRAC) 1 PHARMACY PRACTICE (PHM PRAC) PHM PRAC 305 CONSUMER SELF-CARE AND OVER-THE-COUNTER DRUGS Provides learners with information regarding self-care of common, minor health conditions.
More informationMechanisms of action of bronchial provocation testing
Mechanisms of action of bronchial provocation testing TSANZ / ANZSRS Masterclass: April 3rd, 2016 13:00 13:30 John D. Brannan PhD Scientific Director - Dept. Respiratory & Sleep Medicine John Hunter Hospital,
More informationBangkok (THAILAND) November 10 th - 11 th, International Symposium on:
International Symposium on: COMPLEXITY OF ASTHMA AND ITS COMORBIDITIES Organized by Thoracic Society of Thailand under Royal Patronage Department of Experimental Medicine / University of Rome 'Tor Vergata'
More informationUniversity of Groningen. Symptomatic and asymptomatic airway hyperresponsiveness Jansen, Desiree
University of Groningen Symptomatic and asymptomatic airway hyperresponsiveness Jansen, Desiree IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationUtibron Neohaler. (indacaterol, glycopyrrolate) New Product Slideshow
Utibron Neohaler (indacaterol, glycopyrrolate) New Product Slideshow Introduction Brand name: Utibron Neohaler Generic name: Indacaterol, glycopyrrolate Pharmacological class: Long-acting beta2- agonist
More informationBrand Name: Daliresp. Generic Name: roflumilast. Manufacturer: Forest Pharmaceuticals, Inc.
Brand Name: Daliresp Generic Name: roflumilast 3, 4, 5 Manufacturer: Forest Pharmaceuticals, Inc. 1, 2,4,5,7 Drug Class: Second Generation Phosphodiesterase 4 (PDE 4) inhibitor Labeled Uses: prophylaxis
More informationUniversity of California, San Francisco School of Medicine, Dept of Surgery, Trauma Fellowship at San Francisco General Hospital Program Description
University of California, School of Medicine, Dept of Surgery, at Program Description A. PROGRAM DEMOGRAPHICS Name of Host Institution Program Specialty/Subspecialty Program Mailing Address Program Physical
More informationTingting Zhang Cell Phone: EDUCATION Ph.D. in Pharmacoepidemiology July 2013
Tingting Zhang Tingting_zhang@brown.edu Cell Phone: 1-339-206-3938 EDUCATION Ph.D. in Pharmacoepidemiology July 2013 University of British Columbia Vancouver, Canada Dissertation: Asthma drug regimen optimality
More informationArginine and Asthma. Claudia R. Morris
Modulation of Immune Responses and Nutrition Makrides M, Ochoa JB, Szajewska H (eds): The Importance of Immunonutrition. Nestlé Nutr Inst Workshop Ser, vol 77, pp 1 15, ( DOI: 10.1159/000351365 ) Nestec
More informationBasic mechanisms disturbing lung function and gas exchange
Basic mechanisms disturbing lung function and gas exchange Blagoi Marinov, MD, PhD Pathophysiology Department, Medical University of Plovdiv Respiratory system 1 Control of breathing Structure of the lungs
More informationThe Link Between Viruses and Asthma
The Link Between Viruses and Asthma CATHERINE KIER, MD Professor of Clinical Pediatrics Division Chief, Pediatric Pulmonary, and Cystic Fibrosis Center Director, Pediatric Sleep Disorders Center SUNY Stony
More informationSalmeterol, a new long acting inhaled,f2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients
Thorax 1988;43:674-678 Salmeterol, a new long acting inhaled,f2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients ANDERS ULLMAN, NILS SVEDMYR From the Department of Clinical
More informationExercise in Adverse Cardiac Remodeling: of Mice and Men
Exercise in Adverse Cardiac Remodeling: of Mice and Men 17-01-2013 Dirk J Duncker Experimental Cardiology, Cardiology, Thoraxcenter Cardiovascular Research Institute COEUR Erasmus MC, University Medical
More informationProperty of Presenter
Have We Missed A Role For Neutrophils In Asthma? In Steroid-Refractory Asthma? Erwin W. Gelfand, MD Chairman, Department of Pediatrics National Jewish Health Professor of Pediatrics and Immunology University
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationIdentifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations
Identifying Biologic Targets to Attenuate or Eliminate Exacerbations exacerbations are a major cause of disease morbidity and costs. For both children and adults, viral respiratory infections are the major
More informationUniversity of Groningen. Compartmentalized signaling in the lung Poppinga, Wilfred Jelco
University of Groningen Compartmentalized signaling in the lung Poppinga, Wilfred Jelco IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
More informationPharmacological Assessment of the In Vitro Functional Selectivity of Aclidinium Bromide at M 3 and M 2 Muscarinic Receptors in Human Tissue
Pulm Ther (2015) 1:103 107 DOI 10.1007/s41030-015-0003-x BRIEF REPORT Pharmacological Assessment of the In Vitro Functional Selectivity of Aclidinium Bromide at M 3 and M 2 Muscarinic Receptors in Human
More informationOptimization of the GeneBLAzer H2 CRE-bla HEK 293T Cell Line
GeneBLAzer Validation Packet Version No.: 1Sep Page 1 of 5 Optimization of the GeneBLAzer H CRE-bla HEK 93T Cell Line GeneBLAzer H HEK 93T DA Cells GeneBLAzer H CRE-bla HEK 93T Cells Catalog Numbers K17
More informationSmall Airways Disease. Respiratory Function In Small Airways And Asthma. Pathophysiologic Changes in the Small Airways of Asthma Patients
Small Airways Disease Respiratory Function In Small Airways And Relevant Questions On Small Airway Involvement In How can small airway disease be defined? What is the link between small airway abnormalities
More informationMethacholine versus Mannitol Challenge in the Evaluation of Asthma Clinical applications of methacholine and mannitol challenges
Methacholine versus Mannitol Challenge in the Evaluation of Asthma Clinical applications of methacholine and mannitol challenges AAAAI San Antonio Tx February 2013 Catherine Lemière MD, MSc Hôpital du
More informationMuscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells
Eur Respir J 29; 34: 1436 1443 DOI: 1.1183/931936.4529 CopyrightßERS Journals Ltd 29 Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells
More informationClinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy
Clinical Implications of Asthma Phenotypes Michael Schatz, MD, MS Department of Allergy Definition of Phenotype The observable properties of an organism that are produced by the interaction of the genotype
More informationPharmacological Management of Obstructive Airways in Humans. Introduction to Scientific Research. Submitted: 12/4/08
Pharmacological Management of Obstructive Airways in Humans Introduction to Scientific Research Submitted: 12/4/08 Introduction: Obstructive airways can be characterized as inflammation or structural changes
More informationMessage From the Assembly Chairman Sally Wenzel, M.D.
ALLERGY, IMMUNOLOGY AND INFLAMMATION ASSEMBLY NEWSLETTER EDITED BY SALLY WENZEL, ASSEMBLY CHAIRMAN SPRING 2005 Officers of the Assembly on AIIergy, Immunology and Inflammation Assembly Chairman 2003-2005:
More informationAristoteles et al. BMC Pulmonary Medicine 2013, 13:52
Aristoteles et al. BMC Pulmonary Medicine 213, 13:52 RESEARCH ARTICLE Open Access Modulation of the oscillatory mechanics of lung tissue and the oxidative stress response induced by arginase inhibition
More informationCOPYRIGHTED MATERIAL. Definition and Pathology CHAPTER 1. John Rees
CHAPTER 1 Definition and Pathology John Rees Sherman Education Centre, Guy s Hospital, London, UK OVERVIEW Asthma is an overall descriptive term but there are a number of more or less distinct phenotypes
More information